Inventor · disambiguated record
Mark Edward Zak
Also filed as: ZAK MARK · ZAK MARK E · ZAK MARK EDWARD
22 granted patents·38 pending applications·132 citations·filing 2009–2024
94Inventor score
Top patents by PatentIndex Score
60 records- 0194US9822129B2Amido spirocyclic amide and sulfonamide derivativesGENENTECH INC·Filed 2013·Granted Nov 21, 2017·26 cites·35 claims
- 0293US9458172B2Pyridinyl and pyrimidinyl sulfoxide and sulfone derivativesBAIR KENNETH W·Filed 2013·Granted Oct 4, 2016·25 cites·20 claims
- 0391US11485745B2Amido spirocyclic amide and sulfonamide derivativesVALO HEALTH INC·Filed 2020·Granted Nov 1, 2022·2 cites·19 claims
- 0491US9346815B25-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2015·Granted May 24, 2016·5 cites·20 claims
- 0589US10730889B2Amido spirocyclic amide and sulfonamide derivativesFORMA TM LLC·Filed 2018·Granted Aug 4, 2020·6 cites·16 claims
- 0689US8461328B2Tricyclic heterocyclic compounds, compositions and methods of use thereofBABU SRINIVASAN·Filed 2011·Granted Jun 11, 2013·36 cites·18 claims
- 0788US9604984B25-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2016·Granted Mar 28, 2017·4 cites·21 claims
- 0887US8999998B2Pyrazolopyrimidine JAK inhibitor compounds and methodsGIBBONS PAUL·Filed 2010·Granted Apr 7, 2015·7 cites·1 claims
- 0986US10307426B2Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Granted Jun 4, 2019·4 cites·29 claims
- 1085US7923456B25-anilinoimidazo[1,5-a]-pyridines inhibitors of MEK kinaseGENENTECH INC·Filed 2009·Granted Apr 12, 2011·7 cites·17 claims
- 1185US2024150364A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1281US10696692B2Amido-benzyl sulfone and sulfoxide derivatesFORMA TM LLC·Filed 2013·Granted Jun 30, 2020·6 cites·4 claims
- 1377US2022389020A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2022·Application pending·0 cites
- 1475US2023242530A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2023·Application pending·0 cites
- 1574US11155557B2Pyrazolopyrimidine compounds and methods of use thereofGENENTECH INC·Filed 2019·Granted Oct 26, 2021·1 cites·19 claims
- 1673US9873709B2Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Granted Jan 23, 2018·1 cites·14 claims
- 1773US2024400587A1Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1872US2023206644A1Pyrazolopyrimidine compounds as jak inhibitorsGENENTECH INC·Filed 2023·Application pending·0 cites
- 1972US2022204517A1Inhaled powder formulationsGENENTECH INC·Filed 2022·Application pending·0 cites
- 2071US2020002345A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2019·Application pending·0 cites
- 2170US11649241B2Pyrazolochlorophenyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2021·Granted May 16, 2023·0 cites·4 claims
- 2270US2022024945A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 2369US2019322661A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2468US12247032B2Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of JAK kinasesGENENTECH INC·Filed 2022·Granted Mar 11, 2025·0 cites·1 claims
- 2568US12091426B2Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Sep 17, 2024·0 cites·29 claims
- 2668US11795170B2Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2020·Granted Oct 24, 2023·0 cites·2 claims
- 2768US8288408B25-anilinoimidazopyridines and methods of usePRICE STEPHEN·Filed 2011·Granted Oct 16, 2012·1 cites·3 claims
- 2868US2019240227A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2967US8722661B2Pyrrolopyrimidone and pyrrolopyridone inhibitors of tankyraseGENENTECH INC·Filed 2013·Granted May 13, 2014·1 cites·11 claims
- 3065US2020352951A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 3164US11731943B2Therapeutic compounds, compositions and methods of use thereofGENENTECH INC·Filed 2021·Granted Aug 22, 2023·0 cites·8 claims
- 3264US2017283424A1Pyrazolopyrimidine jak inhibitor compounds and methodsGENENTECH INC·Filed 2017·Application pending·0 cites
- 3364US2023016791A1Inhalable dry powder and aerosol formulations of jak inhibitorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 3464US2018305355A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 3562US2019202822A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 3661US2020339604A1Pyrazolopyrimidine compounds as jak inhibitorsGENENTECH INC·Filed 2020·Application pending·0 cites
- 3761US2020165260A1Inhaled powder formulationsGENENTECH INC·Filed 2020·Application pending·0 cites
- 3861US2020270248A18-(azetidin-1-yl)-[1,2,4]triazolo[1,5-a]pyridinyl compounds, compositions and methods of use thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 3960US2017145020A15-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds,compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4060US2019233441A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4159US2020062779A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4259US2019337946A1Triazolopyridine compounds and methods of use thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 4357US11453671B2Pyrazolopyrimidine inhibitors of JAK kinases and uses thereofGENENTECH INC·Filed 2020·Granted Sep 27, 2022·0 cites·12 claims
- 4457US2020399274A1Tetrazole-substituted pyrazolopyrimidine inhibitors of jak kinases and uses thereofGENENTECH INC·Filed 2020·Application pending·0 cites
- 4557US2018298033A1Triazolopyridine compounds, compositions and methods of use thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 4656US2018265515A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 4756US2018327402A1Triazolopyridine compounds and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 4856US2017216262A1Amido spirocyclic amide and sulfonamide derivativesBAIR KENNETH W·Filed 2017·Application pending·0 cites
- 4956US2018334465A1Therapeutic compounds and compositions, and methods of use thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 5054US2012309765A15-anilinoimidazopyridines and methods of usePRICE STEPHEN·Filed 2012·Application pending·0 cites
Showing the top 50 of 60 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →